◀ Back to TGFB2

TGFB2 — TGM2

Text-mined interactions from Literome

Welge-Lüssen et al., Invest Ophthalmol Vis Sci 2000 : Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta1 and TGF-beta2
Fuchshofer et al., Invest Ophthalmol Vis Sci 2005 : To study whether glaucomatous extracellular matrix ( ECM ) modifications in the lamina cribrosa might be induced by TGF-beta 2, the effect of TGF-beta 2 on the expression of collagen types I ( Col1 alpha 1 ), III ( Col3 alpha 1 ), and IV ( Col4 alpha 2 ) ; fibronectin ( FN ) ; tissue transglutaminase ( TGM2 ) ; connective tissue growth factor (CTGF) ; and thrombospondin ( TSP-1 ) in cultured human optic nerve head ( ONH ) astrocytes was investigated
Boisvert et al., Arterioscler Thromb Vasc Biol 2006 (Atherosclerosis...) : Transglutaminase 2 (TG2) , a broadly expressed regulator of protein cross linking, wound healing, and tissue fibrosis, mediates apoptotic cell ingestion and transforming growth factor-beta release by macrophages and thereby can limit leukocyte mediated inflammation
Kojima et al., J Cell Physiol 1995 : The activation of latent transforming growth factor-beta ( TGF-beta ) by vascular endothelial cells ( ECs ) is regulated by cellular plasminogen activator (PA)/plasmin, transglutaminase ( TGase ) , and latent TGF-beta levels
Kojima et al., J Cell Biol 1993 : Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells